EuroEyes Announces Availability of 2026 Interim Report and Outlines Shareholder Communication Options

Bulletin Express
昨天

EuroEyes International Eye Clinic Limited released a shareholder notification dated 22 September 2026 confirming that its 2026 Interim Report is now accessible in both English and Chinese on the company’s website (ir.euroeyes.hk) and on the Hong Kong Stock Exchange’s HKEXnews platform (www.hkexnews.hk).

The board recommends stakeholders use the online version for immediate access. Non-registered shareholders who are unable to view or receive the electronic document may request a hard copy—free of charge—by completing and returning the enclosed request form to the Hong Kong branch share registrar, Tricor Investor Services Limited, via post (pre-paid label provided) or email (1846-ecom@vistra.com).

Investors holding shares through intermediaries (banks, brokers, custodians, nominees or HKSCC Nominees Limited) can opt to receive future corporate communications electronically by supplying their functional email address to those intermediaries. Until a valid email is on record, such investors will continue to receive printed notices of publication by post.

Queries can be directed to Tricor Investor Services Limited’s hotline on +852 2980 1333 during business hours (9:00 a.m.–6:00 p.m., Monday to Friday, excluding public holidays).

The notification was issued by Dr. Jørn Slot Jørgensen, Chairman and Executive Director of EuroEyes International Eye Clinic Limited, on behalf of the board.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10